JWH-073

JWH-073 is a synthetic cannabinoid receptor agonist belonging to the naphthoylindole family. It was developed during scientific research into compounds that interact with the endocannabinoid system, particularly the cannabinoid CB1 and CB2 receptors.

It is structurally related to JWH-018, but JWH-073 has a four-carbon butyl side chain rather than the five-carbon pentyl chain found in JWH-018. This difference affects its receptor-binding characteristics, metabolism and analytical profile.

JWH-073 is not a naturally occurring cannabinoid. It is not an approved medicine, food ingredient, dietary supplement or consumer product. Its legitimate applications are primarily limited to analytical chemistry, forensic toxicology, cannabinoid-receptor research and authenticated laboratory reference standards.

Chemical information

• Common name: JWH-073
• Chemical class: Naphthoylindole synthetic cannabinoid
• Chemical name: Naphthalen-1-yl(1-butyl-1H-indol-3-yl)methanone
• Alternative description: 1-butyl-3-(1-naphthoyl)indole
• Molecular formula: C₂₃H₂₁NO
• Molecular weight: Approximately 327.43 g/mol
• Commonly reported CAS number: 208987-48-8
• Intended context: Analytical, forensic and scientific laboratory research

Physical appearance cannot confirm chemical identity. An unknown powder or solid should only be identified using authenticated analytical methods and traceable reference material.

Pharmacological characteristics

JWH-073 acts as an agonist at cannabinoid receptors. Laboratory research has demonstrated activity at both CB1 and CB2 receptors.

CB1 receptors are concentrated primarily in the central nervous system and are involved in functions such as:

• Memory
• Coordination
• Perception
• Appetite
• Mood
• Pain signalling

CB2 receptors occur mainly in immune and peripheral tissues, although they may also be present in parts of the nervous system.

 JWH-073 as a cannabinoid-receptor ligand with activity in the nanomolar range. Exact affinity and potency values vary according to the assay, receptor preparation, species and laboratory method.

Many synthetic cannabinoid receptor agonists can produce stronger or more complete receptor activation than delta-9-tetrahydrocannabinol. Their biological effects may therefore be more intense and less predictable than those associated with conventional cannabis.

Research applications

Authenticated JWH-073 reference material may be used in controlled laboratory settings for:

• Cannabinoid receptor-binding studies
• Endocannabinoid-system research
• Analytical method development
• Forensic toxicology
• Metabolite identification
• Chromatographic comparison
• Mass-spectrometry method validation
• Screening of unknown forensic samples
• Examination of seized materials
• Development of analytical reference standards

Forensic laboratories may compare an unknown sample against an authenticated JWH-073 standard by examining retention time, mass-spectral fragmentation and other analytical characteristics.

Analytical identification

Techniques used to identify JWH-073 may include:

• Gas chromatography–mass spectrometry
• Liquid chromatography–tandem mass spectrometry
• High-resolution mass spectrometry
• Nuclear magnetic resonance spectroscopy
• Infrared spectroscopy
• Chromatographic retention-time comparison

Reliable identification generally requires comparison with authenticated analytical data or a certified reference material.

A properly documented laboratory standard may include:

• Certificate of Analysis
• Batch or lot number
• Purity or assay result
• Chromatographic data
• Mass-spectral information
• Nuclear magnetic resonance data
• Date of analysis
• Storage recommendations
• Quality-control authorization

The batch number printed on the container should match the batch number shown on the accompanying Certificate of Analysis.

Metabolism

JWH-073 undergoes extensive oxidative metabolism. Research has identified multiple metabolites formed through modification of the butyl side chain and other parts of the molecule.

Reported or proposed metabolic pathways include:

• Hydroxylation of the N-butyl side chain
• Oxidation of hydroxylated metabolites
• Formation of carboxylic-acid metabolites
• N-dealkylation
• Aromatic hydroxylation
• Further oxidative transformation
• Conjugation, particularly glucuronidation

Hydroxylated and carboxylated metabolites may remain detectable longer than the unchanged parent compound. Toxicology laboratories may therefore target characteristic metabolites in addition to JWH-073 itself.

The observed metabolite profile can depend on:

• Biological system
• Sample type
• Time of collection
• Analytical method
• Instrument sensitivity
• Sample-preparation procedure

Some metabolites may retain activity at cannabinoid receptors, which is relevant when interpreting toxicological findings.

Toxicology and safety concerns

JWH-073 has not been adequately evaluated for human safety and is not approved for therapeutic, diagnostic, dietary or recreational use.

Synthetic cannabinoid receptor agonists as a broader class have been associated with serious adverse reactions, including:

• Rapid heart rate
• Elevated blood pressure
• Severe anxiety
• Agitation
• Confusion
• Hallucinations
• Psychotic symptoms
• Vomiting
• Seizures
• Loss of consciousness
• Kidney injury
• Cardiovascular complications
• Coma
• Death

These effects are associated with the broader synthetic-cannabinoid class and should not all be interpreted as uniquely established effects of JWH-073. However, the limited human toxicology data and cannabinoid-receptor activity mean accidental exposure should be treated seriously.

JWH-073 is not intended for human or veterinary consumption, self-experimentation, therapeutic administration or household use.

Laboratory handling

JWH-073 should be handled only by trained personnel in an appropriately equipped laboratory.

Suitable controls may include:

• Reviewing the applicable Safety Data Sheet
• Completing a documented risk assessment
• Wearing chemical-resistant gloves
• Using appropriate eye protection
• Wearing protective laboratory clothing
• Avoiding inhalation, ingestion and skin contact
• Using suitable local exhaust ventilation
• Preventing dust or aerosol formation
• Keeping containers securely closed
• Labelling all secondary containers
• Restricting access to authorized personnel
• Preventing cross-contamination
• Maintaining complete receipt and usage records

Personnel should wash thoroughly after handling. Food and beverages should not be present in areas where the material is stored or used.

Storage considerations

Storage requirements should follow the supplier’s authenticated Certificate of Analysis and Safety Data Sheet.

General laboratory principles include:

• Store in a tightly closed and clearly labelled container
• Protect from unauthorized access
• Avoid unnecessary exposure to heat, moisture and light
• Keep incompatible materials separated
• Record the date received and opened
• Monitor any specified refrigeration or freezing conditions
• Maintain accurate inventory records

Batch-specific documentation should take priority over general storage advice.

Quality verification

Before using JWH-073 in laboratory research, verify:

• Product identity
• Batch or lot number
• Purity or assay information
• Analytical method
• Certificate authenticity
• Storage requirements
• Container integrity
• Date of analysis
• Intended research purpose
• Legal authorization

Packaging, colour and physical appearance do not establish purity or identity. Verification should rely on analytical evidence and traceable documentation.

Legal status

JWH-073 is controlled or restricted in many jurisdictions. It may also fall under broad synthetic-cannabinoid, analogue or generic drug-control laws even where it is not listed by name.